Schapira on Breast Cancer and Survivorship

 
 
  • Individualized Cancer Survivorship Dr Kevin Oeffinger, cochair of the 2016 Cancer Survivorship Symposium, outlines an approach to cancer survivorship that tailors care the individual across the oncology/primary care spectrum.
  • Tamoxifen or AI: Breast Cancer Subtypes Narrow Choice In early breast cancer, the biologic subtype provides a clue to the optimal choice of adjuvant endocrine therapy, as indicated by data from BIG 1-98 and discussed by Dr Lidia Schapira.
  • Sex After Cancer: The Unaddressed Issue Sex is not a regular topic between oncologist and patient. But Dr Don Dizon says it should be, given that a large majority of cancer patients and survivors have issues of sexual function.